9,265,760 and 9,339,499, which relate to methods of treating patients with mild and moderate hepatic impairment with hydrocodone bitartrate
, to be infringed, but invalid.
, tramadol hydrochloride, and oxycodone hydrochloride were the most common opioids used (59.4, 21.2, and 18.3 percent, respectively).
The patient was discharged from the surgery center the same day with a prescription for oral hydrocodone bitartrate
and acetaminophen for pain.
Pharmaceuticals company Acella Pharmaceuticals LLC reported on Thursday the receipt of approval from the Food and Drug Administration's approval for its abbreviated new drug application (ANDA) for a Hydrocodone Bitartrate
and Chlorpheniramine Maleate Oral Solution 5 mg/4 mg per 5 ml as a bioequivalent product.
(NASDAQ: PTX) has closed its acquisition of the Zohydro ER (hydrocodone bitartrate
) franchise, the company said on Friday.
Enter Zohydro (Zohydro[TM] ER, hydrocodone bitartrate
): considered a somewhat "tainted" approval by the FDA October 25, 2013 (even after an advisory committee of independent experts voted 11-2 against approval, because of concerns about addiction).
Purdue Pharma LP's hydrocodone bitartrate
tablet (HYD) is undergoing "priority review" by the Food and Drug Administration (FDA), the company recently announced.
Deval Patrick (D) has ordered the state's public health department to ban extended release hydrocodone bitartrate
(Zohydro ER) until die state has determined that measures are in place to safeguard against its abuse.
Joe Manchin (D-W.Va.) wants the Department of Health & Human Services to overturn the Food and Drug Administration's approval of extended release hydrocodone bitartrate
Vicodin, a combination of the powerful opioid pain reliever hydrocodone bitartrate
and acetaminophen, is being reclassified as "possibly'' highly addictive and prone to abuse, and will now be considered a schedule II drug.
Zogenix's lead investigational product candidate, Zohydro ER (hydrocodone bitartrate
extended release capsules), is an oral, extended-release formulation of various strengths of hydrocodone, without acetaminophen, intended for administration every 12 hours for around the clock management of moderate to severe chronic pain.